David R. LaVance Jr. was voted in as a new member of Hologic's board of directors at the Feb. 25 annual stockholders meeting. LaVance founded and has served as president of Century Capital Associates, an investment banking firm specializing in
David R. LaVance Jr. was voted in as a new member of Hologic's board of directors at the Feb. 25 annual stockholders meeting. LaVance founded and has served as president of Century Capital Associates, an investment banking firm specializing in bioscience. Previously, he was managing director for KPMG Health Ventures, a life sciences consulting practice of the KPMG accounting firm.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.